• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

JCI Insight . Emergence of dysfunctional neutrophils with a defect in arginase-1 release in severe COVID-19

tetano

Editor, Senior Moderator
JCI Insight


. 2024 Sep 10;9(17):e171659.
doi: 10.1172/jci.insight.171659. Emergence of dysfunctional neutrophils with a defect in arginase-1 release in severe COVID-19

Amrita Dwivedi[SUP] 1 [/SUP], Aisling Ui Mhaonaigh[SUP] 1 [/SUP], Makala Carroll[SUP] 1 [/SUP], Bahareh Khosravi[SUP] 1 [/SUP], Isabella Batten[SUP] 2 [/SUP], Robert Seán Ballantine[SUP] 1 [/SUP], Stuart Hendricken Phelan[SUP] 3 [/SUP], Laura O'Doherty[SUP] 3 4 [/SUP], Angel Mary George[SUP] 5 [/SUP], Jacklyn Sui[SUP] 2 5 [/SUP], Heike C Hawerkamp[SUP] 6 [/SUP], Padraic G Fallon[SUP] 6 7 [/SUP], Elnè Noppe[SUP] 8 [/SUP], Sabina Mason[SUP] 8 [/SUP], Niall Conlon[SUP] 4 5 [/SUP], Clíona Ni Cheallaigh[SUP] 4 [/SUP], Conor M Finlay[SUP] 1 [/SUP], Mark A Little[SUP] 1 [/SUP], On Behalf Of The St James's And Tallaght Trinity Allied Researchers Sttar Bioresource[SUP] 9 [/SUP]



Affiliations
Free article Abstract

Neutrophilia occurs in patients infected with SARS-CoV-2 (COVID-19) and is predictive of poor outcomes. Here, we link heterogenous neutrophil populations to disease severity in COVID-19. We identified neutrophils with features of cellular aging and immunosuppressive capacity in mild COVID-19 and features of neutrophil immaturity and activation in severe disease. The low-density neutrophil (LDN) number in circulating blood correlated with COVID-19 severity. Many of the divergent neutrophil phenotypes in COVID-19 were overrepresented in the LDN fraction and were less detectable in normal-density neutrophils. Functionally, neutrophils from patients with severe COVID-19 displayed defects in neutrophil extracellular trap formation and reactive oxygen species production. Soluble factors secreted by neutrophils from these patients inhibited T cell proliferation. Neutrophils from patients with severe COVID-19 had increased expression of arginase-1 protein, a feature that was retained in convalescent patients. Despite this increase in intracellular expression, there was a reduction in arginase-1 release by neutrophils into serum and culture supernatants. Furthermore, neutrophil-mediated T cell suppression was independent of arginase-1. Our results indicate the presence of dysfunctional, activated, and immature neutrophils in severe COVID-19.

Keywords: COVID-19; Immunology; Neutrophils.

 
Back
Top Bottom